|
[Related PubMed/MEDLINE]
Total Number of Papers: 84
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: CFRD |
| Long Form |
: CF-related diabetes |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Abnormal glucose tolerance and the 50-gram glucose challenge test in Cystic fibrosis. |
CF, GCT, OGTT |
| 2 |
2020 |
Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment. |
CF, CFTR |
| 3 |
2020 |
Cystic fibrosis-related diabetes: The unmet need. |
CF |
| 4 |
2020 |
Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries. |
CF |
| 5 |
2020 |
Dyslipidemia is not associated with the development of glucose intolerance or diabetes in cystic fibrosis. |
CF |
| 6 |
2020 |
Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits. |
CF, PRSs, T1D, T2D |
| 7 |
2020 |
Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis. |
CF, CFTR, scRNA-seq |
| 8 |
2020 |
Influence of Cystic Fibrosis-Related Diabetes on Mental Health in Adults: A Single-Center Study. |
CF |
| 9 |
2020 |
Some young adults with cystic fibrosis-related diabetes may safely stop insulin without any adverse clinical sequelae. |
CF |
| 10 |
2019 |
Effects of aerobic interval training on glucose tolerance in children and adolescents with cystic fibrosis: a randomized trial protocol. |
AIT, CF, CFDR |
| 11 |
2019 |
Extra-respiratory comorbidities and transplantation in the French cystic fibrosis registry. |
CF, LT |
| 12 |
2019 |
Glucose tolerance in Canadian and French cystic fibrosis adult patients. |
BMI, CF |
| 13 |
2019 |
Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis. |
ALT, CF, NAFLD, OGTT |
| 14 |
2019 |
Mutations in the HFE gene can be associated with increased lung disease severity in cystic fibrosis. |
CF, DIOS, MI |
| 15 |
2019 |
Pre-transplant factors associated with mortality after lung transplantation in cystic fibrosis: A systematic review and meta-analysis. |
Bcc, BMI, CF, NOS |
| 16 |
2019 |
Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c. |
1,5-AG, 2hG, CF, FA, FEV1, FVC, GA, HbA1c, OGTT |
| 17 |
2019 |
The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity. |
AGT, CF |
| 18 |
2018 |
Prevalence of hypoglycemia during oral glucose tolerance testing in adults with cystic fibrosis and risk of developing cystic fibrosis-related diabetes. |
CF, OGTT, PG |
| 19 |
2018 |
Relationship between exercise capacity and glucose tolerance in cystic fibrosis. |
AGT, EC, NGT, OGTT |
| 20 |
2017 |
CFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells. |
CF, CFTR |
| 21 |
2017 |
Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis. |
ABPA, Af, CF, PA |
| 22 |
2017 |
Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008-2012. |
CF, CFTR, MRSA, ppFEV1 |
| 23 |
2016 |
Glucose Fluctuations are Not Modulated by the Proportion of Calories from Macronutrients or Spontaneous Total Energy Expenditure in Adults with Cystic Fibrosis. |
CF, TEE |
| 24 |
2016 |
Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes. |
CF, OGTT |
| 25 |
2016 |
How patients' representations of cystic fibrosis-related diabetes inform their health behaviours. |
CF |
| 26 |
2016 |
Hyperglycaemia and Pseudomonas aeruginosa acidify cystic fibrosis airway surface liquid by elevating epithelial monocarboxylate transporter 2 dependent lactate-H+ secretion. |
ASL, CF, HBE, MCTs |
| 27 |
2016 |
Screening for Cystic Fibrosis-Related Diabetes: Matching Pathophysiology and Addressing Current Challenges. |
CF, OGTT |
| 28 |
2016 |
The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis. |
CF, OGTT |
| 29 |
2016 |
Under Utilization of Pancreas Transplants in Cystic Fibrosis Recipients in the United Network Organ Sharing (UNOS) Data 1987-2014. |
CF, UNOS |
| 30 |
2015 |
Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance. |
CF, CON, DI, NGT, OGTT |
| 31 |
2015 |
Elevation of one hour plasma glucose during oral glucose tolerance testing. |
CF |
| 32 |
2015 |
Evidence for a Cystic Fibrosis Enteropathy. |
CF, EPI, I-FABP, PPI |
| 33 |
2015 |
Insulin secretion abnormalities in exocrine pancreatic sufficient cystic fibrosis patients. |
CF, OGTT |
| 34 |
2015 |
Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues. |
CF, CFTR |
| 35 |
2015 |
Overweight and obesity in patients with cystic fibrosis: a center-based analysis. |
CF, OSA |
| 36 |
2015 |
The role of receptor for advanced glycation end products in airway inflammation in CF and CF related diabetes. |
AGE, CF, es, FL, RAGE |
| 37 |
2014 |
Cystic fibrosis related diabetes--a new perspective on the optimal management of postprandial glycemia. |
CF, GIP, GLP-1, T2D |
| 38 |
2014 |
Cystic fibrosis related diabetes: potential pitfalls in the transition from paediatric to adult care. |
ADA, CF, ISPAD |
| 39 |
2014 |
Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study. |
CF, CFTR, IRT |
| 40 |
2014 |
Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry. |
BMI, CF, ECFSPR, FEV1 |
| 41 |
2014 |
Glucose-induced electrical activities and insulin secretion in pancreatic islet beta-cells are modulated by CFTR. |
CF, CFTR |
| 42 |
2014 |
Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test. |
CF, IFG, IGT, NGT, OGTT, OR |
| 43 |
2013 |
Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients. |
CF, FEV1, HR |
| 44 |
2013 |
Diagnosis of cystic fibrosis-related glucose abnormalities: Can we shorten the standard oral glucose tolerance test? |
APCF, IGT, OGTT, ROC-AUC |
| 45 |
2013 |
Genetic modifiers of cystic fibrosis-related diabetes. |
CF, CFTR, HR, SNPs |
| 46 |
2013 |
Outcome of cystic fibrosis-related diabetes two years after lung transplantation. |
CF, LT |
| 47 |
2013 |
Progression of structural lung disease on CT scans in children with cystic fibrosis related diabetes. |
CF, CT, IGT, NGT |
| 48 |
2013 |
The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis. |
BMC, BMD, FN, IGT, LS, NGT, TB, vBMD |
| 49 |
2012 |
Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets. |
CF |
| 50 |
2012 |
Cystic fibrosis: a clinician's tool for management of care advancing into the adult population. |
CF, CFF, CFLD |
| 51 |
2012 |
Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis. |
ABPA, CF, CRP, PA, TUNE |
| 52 |
2012 |
Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype. |
AIR, CF, FGIR, FPIR, HOMA-IR, IGT |
| 53 |
2012 |
Screening for cystic fibrosis-related diabetes: a systematic review. |
BG, CF |
| 54 |
2012 |
Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study. |
CF, TIVAD |
| 55 |
2012 |
[Abnormal glucose tolerance in prepubertal patients with cystic fibrosis]. |
AGT, CF, IGT, INDET, NGT, OGTT |
| 56 |
2011 |
Risk factors for chronic kidney disease in adults with cystic fibrosis. |
CF, CI, HR |
| 57 |
2010 |
Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system. |
CF, CGMS, IGT, OGTT |
| 58 |
2010 |
Combined pancreatic islet-lung transplantation: a novel approach to the treatment of end-stage cystic fibrosis. |
CF |
| 59 |
2010 |
MRI appearance of the pancreas in patients with cystic fibrosis: a comparison of pancreas volume in diabetic and non-diabetic patients. |
CF |
| 60 |
2010 |
Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program. |
CF, FH, IGT, NGT, OGTTs, PI |
| 61 |
2010 |
Prevalence of dyslipidemia in adults with cystic fibrosis. |
CF, PI |
| 62 |
2010 |
The size of the spleen by magnetic resonance imaging in patients with cystic fibrosis; with and without diabetes--a novel observational study. |
BMI, CF, HbA1c, MRI, T1DM |
| 63 |
2009 |
Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress. |
CF, CFTR |
| 64 |
2009 |
Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: a pilot study. |
CF, FFA, NGT, OGTT, TG, TM |
| 65 |
2009 |
Increased augmentation index in patients with cystic fibrosis. |
AIx, CF, CRP, PWV |
| 66 |
2009 |
[Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis]. |
CF, CGMS |
| 67 |
2008 |
Bilateral sequential lung and simultaneous pancreas transplant: a new approach for the recipient with cystic fibrosis. |
CF |
| 68 |
2008 |
CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes. |
CF, LR, SI, STZ |
| 69 |
2008 |
Simultaneous bilateral lung and pancreas transplantation in recipient with cystic fibrosis. |
CF |
| 70 |
2006 |
Calpain 10 and development of diabetes mellitus in cystic fibrosis. |
CF, DM, NGT |
| 71 |
2006 |
Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance. |
BMI, CF, IGT, OGTT |
| 72 |
2005 |
Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. |
CF |
| 73 |
2005 |
Effect of nebulized albuterol on blood glucose in patients with diabetes mellitus with and without cystic fibrosis. |
CF, DM |
| 74 |
2005 |
Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. |
BMI, CF, FVC |
| 75 |
2005 |
Simultaneous liver and pancreas transplantation in patients with cystic fibrosis. |
CF |
| 76 |
2003 |
Management of cystic fibrosis-related diabetes in adolescence. |
CF |
| 77 |
2002 |
Diagnosis, screening, and management of cystic fibrosis-related diabetes. |
CF |
| 78 |
2002 |
Invasive mechanical ventilation for acute respiratory failure in children with cystic fibrosis: outcome analysis and case-control study. |
ARF, CF, FVC, HEM, IMV, PTX |
| 79 |
2001 |
Glucose intolerance in cystic fibrosis patients. |
CF |
| 80 |
2001 |
Mechanisms of insulin resistance in cystic fibrosis. |
CF, FFA, GDR, IGT, NIH, TNF |
| 81 |
2000 |
Cystic fibrosis-related diabetes: an approach to diagnosis and management. |
CF |
| 82 |
2000 |
Pathogenesis of malnutrition in cystic fibrosis, and its treatment. |
GE, RMR, TDEE |
| 83 |
1999 |
Diabetes mellitus in cystic fibrosis. |
CF |
| 84 |
1998 |
Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S. |
ATS, CF, IGT, LWPES |
|
A Search Service for Abbreviation / Long Form
